Calcium-channel blockade and incidence of cancer in aged populations

Lancet

Volumn 348, Issue 9026, 1996, Pages 493-497

  Pahor, Marco ^a,d   Guralnik, Jack M ^b   Ferrucci, Luigi ^c   Corti, Maria Chiara ^b   Salive, Marcel E ^b   Cerhan, James R ^e   Wallace, Robert B ^e   Havlik, Richard J ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b Laboratory of Membrane Biochemistry and Biophysics   (United States)

^c Geriatric Department   (Italy)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; COUMARIN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; NIFEDIPINE; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; VERAPAMIL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CAUSE OF DEATH; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DISABILITY; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

EID: 0030600342     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04277-8     Document Type: Article

References (36)

1. 1 Pahor M, Guralnik JM, Corti C, Foley DJ, Carbonin PU, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995; 43: 1191-97.
2. 2 Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
3. 3 Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-25.
4. 4 Furberg CD, Pahor M, Psaty BM. The unnecessary controversy. Eur Heart J 1996; 17: 1142-47.
5. 5 Konrad Dalhoff I, Baunack AR, Ramsch KD, et al. Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J Clin Pharmacol 1991; 41: 313-16.
6. 6 Pahor M, Guralnik JM, Chrischilles EA, Wallace RB. Use of laxative medication in older persons and associations with low serum albumin. J Am Geriatr Soc 1994; 42: 50-56.
7. 7 Wagenknecht LE, Furberg CD, Hammon JW, Legault C, Troost BT. Surgical bleeding: unexpected effect of a calcium antagonist. BMJ 1995; 310: 776-77.
8. 8 Pahor M, Guralnik JM, Furberg CD, Carbonin PU, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347: 1061-65.
9. 9 Stein G, Srivastava MK, Merker HJ, Neubert D. Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture. Arch Toxicol 1990; 64: 623-38.
10. 10 Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like lesions. N Engl J Med 1995; 333: 1429.
11. 11 Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9: 695-99.
12. 12 Connor J, Sawczuk IS, Benson MC, et al. Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate 1988; 13: 119-30.
13. 2+ channels exposed to serum from patients with type I diabetes. Science 1993; 261: 86-90.
14. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993; 7: 453-63.
15. 15 Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-54.
16. 16 Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995; 9: 219-28.
17. 17 Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 1995; 18: 137-53.
18. 18 Whitfield JF. Calcium signals and cancer. Crit Rev Oncog 1992; 3: 55-90.
19. 19 Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; i: 307-09.
20. 20 Cornoni-Huntley J, Ostfeld AM, Taylor JO, et al. Established populations for epidemic studies of the elderly: study design and methodology. Aging Clin Exp Res 1993; 5: 27-37.
21. 21 Stampfer MJ, Willett WC, Speizer FE, Dysert DC. Test of the National Death Index. Am J Epidemiol 1984; 119: 837-39.
22. 22 Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Hlth 1992; 82: 243-48.
23. 23 SEER cancer statistics review, 1973-1991: tables and graphs, National Cancer Institute. NIH publication No 94-2789. Bethesda, MD: NIH publication no 94-2789, 1994.
24. 24 Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213-20.
25. 25 Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 1992; 45: 638-92.
26. 26 Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin PU. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-11.
27. 27 Rose GA, Blackburn H, Gillum RF, Prineas RJ. Annex 6 - London school of hygiene cardiovascular questionnaire. In: World Health Organisaton. Cardiovascular survey methods, 2nd edn. Geneva: WHO, 1982: 162-65.
28. 28 Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 94-99.
29. 29 Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol 1966; 21: 556-59.
30. 30 Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities; a two-stage screen for hypertension. JAMA 1977; 237: 2385-91.
31. 31 Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11: 197-220.
32. 32 Batra S, Popper LD, Hartley-Asp B. Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells. Prostate 1991; 19: 299-311.
33. 33 Raynor WJ, Shekelle RB, Rossof AH, Maliza M, Paul O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol 1981; 118: 371-77.
34. 34 Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood pressure: a risk factor for cancer mortality? Lancet 1975; i: 1051-56.
35. 35 Furberg CD, Psaty BM. Calcium antagonists: antagonists or protagonists of mortality in elderly hypertensives? J Am Geriatr Soc 1995; 43: 1309-10.
36. 36 Yusuf S. Calcium antagonists in cornary artery disease and hypertension. Time for reevaluation? Circulation 1995; 92: 1079-82.